tradingkey.logo

Xtant Medical Holdings Inc

XTNT
0.591USD
+0.021+3.74%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
82.78MMarktkapitalisierung
45.70KGV TTM

Xtant Medical Holdings Inc

0.591
+0.021+3.74%

mehr Informationen über Xtant Medical Holdings Inc Unternehmen

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc Informationen

BörsenkürzelXTNT
Name des UnternehmensXtant Medical Holdings Inc
IPO-datumJun 30, 2010
CEOBrowne (Sean E)
Anzahl der mitarbeiter217
WertpapierartOrdinary Share
GeschäftsjahresendeJun 30
Addresse664 Cruiser Lane
StadtBELGRADE
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl59714
Telefon14063880480
Websitehttps://xtantmedical.com/
BörsenkürzelXTNT
IPO-datumJun 30, 2010
CEOBrowne (Sean E)

Führungskräfte von Xtant Medical Holdings Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+553797.00%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
914.12K
+158228.00%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
566.93K
-8084.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
+158228.00%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+553797.00%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
914.12K
+158228.00%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
566.93K
-8084.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
+158228.00%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Orthobiologics
17.15M
51.57%
Spinal implant
10.62M
31.94%
License revenue
5.48M
16.49%
Nach RegionUSD
Name
Umsatz
Anteil
United States
30.31M
91.15%
Rest of World
2.94M
8.85%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Orthobiologics
17.15M
51.57%
Spinal implant
10.62M
31.94%
License revenue
5.48M
16.49%

Aktionärsstatistik

Aktualisiert: Sat, Nov 22
Aktualisiert: Sat, Nov 22
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.62%
Andere
32.69%
Aktionäre
Aktionäre
Anteil
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.62%
Andere
32.69%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
49.59%
Individual Investor
16.45%
Investment Advisor/Hedge Fund
5.20%
Investment Advisor
2.29%
Research Firm
0.04%
Andere
26.42%

Institutionelle Beteiligung

Aktualisiert: Wed, Jan 21
Aktualisiert: Wed, Jan 21
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q4
41
80.10M
114.61%
--
2025Q4
60
79.99M
57.14%
-82.24M
2025Q3
58
80.07M
57.19%
-75.11M
2025Q2
66
93.42M
67.06%
-16.04M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
2023Q4
59
100.17M
77.23%
+1.05M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Nantahala Capital Management, LLC
68.39M
48.85%
--
--
Sep 30, 2025
Lytton (Laurence W)
9.46M
6.76%
+9.46M
--
Apr 15, 2025
Vizirgianakis (Stavros G)
7.52M
5.37%
+553.80K
+7.95%
Nov 15, 2025
AWM Investment Company, Inc.
6.59M
4.71%
-2.50K
-0.04%
Sep 30, 2025
The Vanguard Group, Inc.
2.36M
1.68%
+104.16K
+4.63%
Sep 30, 2025
Browne (Sean E.)
1.94M
1.39%
+394.94K
+25.57%
Nov 15, 2025
Beeson (Jonn R.)
1.53M
1.09%
+158.23K
+11.51%
Nov 15, 2025
Bakewell (John K)
1.07M
0.77%
+316.46K
+41.87%
Nov 15, 2025
Renaissance Technologies LLC
713.91K
0.51%
+63.20K
+9.71%
Sep 30, 2025
Neils (Scott C)
575.01K
0.41%
+263.29K
+84.46%
Nov 15, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI